1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Επιστημών Υγείας
  4. Τμήμα Ιατρικής
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22869
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBlanchet, P. J.en
dc.contributor.authorKonitsiotis, S.en
dc.contributor.authorMochizuki, H.en
dc.contributor.authorPluta, R.en
dc.contributor.authorEmerich, D. F.en
dc.contributor.authorChase, T. N.en
dc.contributor.authorMouradian, M. M.en
dc.date.accessioned2015-11-24T19:28:05Z-
dc.date.available2015-11-24T19:28:05Z-
dc.identifier.issn0278-5846-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22869-
dc.rightsDefault Licence-
dc.subjectAnimalsen
dc.subject*Blood-Brain Barrieren
dc.subjectCell Lineen
dc.subjectCell Survivalen
dc.subjectCricetinaeen
dc.subjectDisease Models, Animalen
dc.subjectDopamine/analysisen
dc.subjectFemaleen
dc.subject*Foreign-Body Reactionen
dc.subjectGenetic Engineeringen
dc.subjectGlial Cell Line-Derived Neurotrophic Factoren
dc.subjectInflammationen
dc.subjectKidney/cytologyen
dc.subjectMacaca fascicularisen
dc.subjectMaleen
dc.subjectMembranes, Artificialen
dc.subjectMotor Activityen
dc.subjectNerve Growth Factors/*administration & dosage/pharmacokinetics/pharmacologyen
dc.subjectParkinson Disease/*therapy/veterinaryen
dc.subjectPermeabilityen
dc.subjectPolymersen
dc.subjectTransplantation, Heterologous/*adverse effectsen
dc.titleComplications of a trophic xenotransplant approach in parkinsonian monkeysen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/12787846-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2003-
heal.abstractVarious restorative cell transplantation strategies have been investigated to substitute for lost dopamine (DA) neurons or to enhance DA synthesis in Parkinson's disease. Intracerebral implantation of engineered cells encapsulated in a semipermeable polymer membrane constitutes one way to deliver bioactive substances unable to cross the blood-brain barrier while avoiding the need for long-term immunosuppression. Glial cell line-derived neurotrophic factor (GDNF) has shown trophic effects on DA neurons but effective and sustained delivery within the brain parenchyma remains problematic. The long-term efficacy and late complications of a xenotransplant approach utilizing GDNF-expressing encapsulated baby hamster kidney (BHK) cells were examined. Each of five MPTP-lesioned parkinsonian cynomolgus monkeys received five devices containing active or inert cells grafted bilaterally in the striatum in a two-stage procedure 9 months apart and animals were sacrificed 4 months later for analyses. No definite motor benefit was observed, DA levels were comparable between GDNF- and control cell-implanted striata, and tyrosine hydroxylase (TH) immunoreactivity in the substantia nigra showed no consistent recovery. Cell viability and GDNF synthesis in the explanted devices were negligible. The brain tissue surrounding all implants showed an intense immune reaction with prominent "foreign body" inflammatory infiltrates. Membrane biophysics, the cell type used, and the extended period of time the devices remained in situ may have contributed to the negative outcome and should be addressed in future investigations using this approach.en
heal.journalNameProg Neuropsychopharmacol Biol Psychiatryen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Show simple item record
Files in This Item:
There are no files associated with this item.
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons